C. J. Brindley

Metabolic fate of¹⁴C-camostat mesylate in man, rat and dog after intravenous administration

I. Midgley, Ashley J. Hood, P. Proctor et al. · Xenobiotica · 1994 · 51 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Phase I clinical trial of mitozolomide.

ES Newlands, G. Blackledge, J A Slack et al. · PubMed · 1985 · 51 citations

Pharmacy, Oncology, Pharmacology +16

Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide.

Johann S. de Bono, Angus Dalgleish, J Carmichael et al. · PubMed · 2000 · 49 citations

Medicine, Immunology, Pharmacology +17

Models of schedule dependent haematological toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC)

Lena E. Friberg, C. J. Brindley, Mats O. Karlsson et al. · European Journal of Clinical Pharmacology · 2000 · 42 citations

Medicine, Pharmacology, Toxicology +11

Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat

I. Midgley, Ashley J. Hood, L. F. Chasseaud et al. · Food and Chemical Toxicology · 1992 · 26 citations

Pharmacy, Pharmacokinetics, Pharmacology +10